| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | HERON THERAPEUTICS INC | 4,919,625 | 71,580,000 | 38.07% | ||
| 2 | LA JOLLA PHARMACEUTICAL CO | 2,144,387 | 39,242,000 | 20.87% | ||
| 3 | Opko Health, Inc. | 14,000,000 | 29,439,000 | 15.66% | PRN | |
| 4 | BIOMARIN PHARMACEUTICAL INC | 182,300 | 22,718,000 | 12.08% | ||
| 5 | MIRATI THERAPEUTICS INC | 388,543 | 11,392,000 | 6.06% | ||
| 6 | MERRIMACK PHARMACEUTI | 5,500,000 | 11,154,000 | 5.93% | PRN | |
| 7 | ONCOGENEX PHARMACEUTICALS IN | 628,400 | 1,351,000 | 0.72% | ||
| 8 | RXI PHARMACEUTICALS CORP NEW | 1,572,699 | 1,132,000 | 0.60% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001214659-15-004043, filed 2015.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
